Elicera Therapeutics AB
F:8E8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Elicera Therapeutics AB
F:8E8
|
SE |
|
Maxis Bhd
OTC:MAXSF
|
MY |
|
Metalpha Technology Holding Ltd
NASDAQ:MATH
|
HK |
|
Terra Balcanica Resources Corp
F:UB10
|
CA |
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
DK |
|
Bank Tabungan Negara (Persero) Tbk PT
F:TA2
|
ID |
|
U
|
Univanich Palm Oil PCL
SET:UVAN
|
TH |
|
Musashi Seimitsu Industry Co Ltd
F:67X
|
JP |
|
Cahayasakti Investindo Sukses Tbk PT
IDX:CSIS
|
ID |
|
L
|
Littelfuse Inc
F:LFS
|
US |
|
S
|
Sanu Gold Corp
F:L73
|
CA |
|
Q
|
Quality Concrete Holdings Bhd
KLSE:QUALITY
|
MY |
|
F
|
Forestar Group Inc
F:4F31
|
US |
|
B
|
Bank Danamon Indonesia Tbk PT
XMUN:HX9
|
ID |
|
OSB Group PLC
OTC:OSBGF
|
UK |
|
OSB Group PLC
F:2UK
|
UK |
|
K
|
Kelly Services Inc
F:KYS
|
US |
|
E
|
Elisa Oyj
DUS:EIA
|
FI |
Bankruptcy Probability
Elicera Therapeutics AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Elicera Therapeutics AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Elicera Therapeutics AB
STO:ELIC
|
193.2m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
500.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
234.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
195.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
94.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Elicera Therapeutics AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Elicera Therapeutics AB has no debt.
You can find a full breakdown on its Balance Sheet.